| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | SBC Medical Group Holdings Incorporated: SBC Medical beginnt mit der Entwicklung eines DNA-Methylierungs-Tests zur Einschätzung des biologischen Alters | 422 | Business Wire | Nutzung des Forschungs- und Technologie-Ökosystems der Waqoo-Gruppe zur Etablierung einer neuen persönlichen Basislinie für proaktive Gesundheit und Langlebigkeit Die SBC Medical Group Holdings... ► Artikel lesen | |
| 12.10. | SBC Medical Group Holdings Incorporated: SBC Medical to Present at Cantor Fitzgerald Hong Kong's Inaugural Asia Longevity Forum | 1 | GlobeNewswire (USA) | ||
| 18.09. | SBC Medical Group Holding Q2 2026 Earnings Call Transcript | 1 | Benzinga.com | ||
| 10.09. | ArcStone US Corp.: SBC Medical to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto | 288 | Newsfile | Irvine, California--(Newsfile Corp. - September 10, 2026) - SBC Medical Group Holdings Incorporated (NASDAQ: SBC) ("The Company" or "SBC Medical"), a Medical Services Organization (MSO) providing management... ► Artikel lesen | |
| 02.09. | SBC Medical Group Holdings Incorporated: SBC Medical wird im September 2026 an mehreren bevorstehenden Investorenkonferenzen teilnehmen | 428 | Business Wire | SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("das Unternehmen" oder "SBC Medical"), eine Medical Services Organization (MSO), die Managementunterstützung in einer Vielzahl von Bereichen... ► Artikel lesen | |
| 01.09. | SBC Medical Group Holdings Incorporated: SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026 | 524 | Business Wire | SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("The Company" or "SBC Medical"), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields... ► Artikel lesen | |
| SBC MEDICAL GROUP Aktie jetzt für 0€ handeln | |||||
| 27.08. | Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on SBC Medical Group Holdings Incorporated | 786 | ACCESS Newswire | NEW YORK CITY, NY / ACCESS Newswire / August 27, 2026 / Emerging Growth Research, LLC ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research quarterly update... ► Artikel lesen | |
| 26.08. | SBC Medical Group signalisiert nach Umbau neue Wachstumsphase | 1 | Investing.com Deutsch | ||
| 24.08. | SBC Medical Group Holdings Incorporated: Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00 | 447 | ACCESS Newswire | NEW YORK CITY, NY / ACCESS Newswire / August 24, 2026 / Emerging Growth Research today announced the release of its Q2:26 Quarterly Update Report on SBC Medical Group Holdings (NASDAQ:SBC), reiterating... ► Artikel lesen | |
| 19.08. | SBC Medical Group: Wachstum beschleunigt sich nach Restrukturierungsphase | 1 | Investing.com Deutsch | ||
| 13.08. | SBC Medical Group Holdings Incorporated: SBC Medical Group Holdings gibt die Finanzergebnisse für das zweite Quartal 2026 bekannt | 455 | Business Wire | Umstrukturierung abgeschlossen, Wachstum beschleunigt sich wieder: Umsatz in Q2 um 13 gestiegen, auf SBC Medical entfallender Nettogewinn um 335 gestiegen, bereinigtes EBITDA1 im Vergleich zum Vorjahreszeitraum... ► Artikel lesen | |
| 13.08. | SBC Medical Group Holdings GAAP EPS of $0.10 misses by $0.01, revenue of $49.19M beats by $3.74M | 3 | Seeking Alpha | ||
| 13.08. | SBC Medical übertrifft im zweiten Quartal 2026 die Umsatzerwartungen, verfehlt aber das Gewinnziel | 3 | Investing.com Deutsch | ||
| 13.08. | SBC Medical Group Holdings Inc - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 13.08. | SBC Medical Group Holdings Inc - 8-K, Current Report | 2 | SEC Filings | ||
| 13.08. | SBC Medical Group Holdings Incorporated: SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results | 1.586 | Business Wire | Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Attributable to SBC Medical Up 335%, Adjusted EBITDA1 Up 32% Year-over-Year. AI-Enabled Service Enhancements Drive Successful... ► Artikel lesen | |
| 03.08. | SBC Medical Group Holdings Incorporated: SBC Medical to Announce 2Q 2026 Financial Results | 1 | GlobeNewswire (USA) | ||
| 14.07. | SBC Medical Group Holdings Inc - 8-K, Current Report | 2 | SEC Filings | ||
| 08.07. | SBC Medical Group Holdings Incorporated: SBC Medical Launches Japan's First Specialized Men's Beard Hair Removal Clinic, Introducing a Scalable, Capital-Efficient Growth Platform | 2 | GlobeNewswire (USA) | ||
| 22.05. | SBC Medical to launch aesthetic clinic in Bangkok in June | 1 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 57,82 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,100 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,38 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| NUWELLIS, INC | 5,370 | 0,00 % | Nuwellis: Interview With President And CEO Mike McCormick About Precision Fluid Management And Cardiorenal Care | ||
| SIEMENS HEALTHINEERS | 42,110 | +0,57 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,055 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors | ||
| GENEDX | 62,63 | 0,00 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| BILLIONTOONE | 114,02 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| BETA BIONICS | 21,440 | +0,23 % | Truist reiterates Buy on Beta Bionics stock, $28 target on MINT | ||
| PROGYNY | 27,720 | 0,00 % | Progyny, Inc.: New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model | ||
| KESTRA MEDICAL TECHNOLOGIES | 29,960 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| FRESENIUS | 46,070 | -0,40 % | ANALYSE-FLASH: JPMorgan belässt Fresenius SE auf 'Overweight' - Ziel 55,20 Euro | NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat Fresenius mit einem Kursziel von 55,20 Euro auf "Overweight" belassen. Für die Quartalszahlen des Medizinkonzerns am 4. November liege er beim Umsatz... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,700 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| CONCENTRA GROUP | 40,040 | 0,00 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen |